ArticleLeukemia2021

Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemia.

Julia W Bӧhm et al.PubMed ↗Publisher ↗

No numbers read from the abstract.